Evidence map›Paper›PMID 32244822›Full record

ReviewCancers2020

Green Chemistry Synthesis of Silver Nanoparticles and Their Potential Anticancer Effects.

Zubair Ahmed Ratan, Mohammad Faisal Haidere, Md Nurunnabi, Sadi Md Shahriar, A J Saleh Ahammad, Youn Young Shim, Martin J T Reaney, Jae Youl Cho

Abstract readReview
In one paragraph

Review in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Frontiers in pharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Green Synthesis of Gold Nanoparticles UsingPharmaceuticals (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zubair Ahmed RatanDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.
Mohammad Faisal HaidereDepartment of Public Health and Informatics, Bangabandhu Sheikh Mujib Medical University, Dhaka 1000, Bangladesh.
Md NurunnabiDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Texas at El Paso, El Paso, TX 79902, USA.
Sadi Md ShahriarDepartment of Materials Science and Engineering, Khulna University of Engineering and Technology, Khulna 9203, Bangladesh.
A J Saleh AhammadDepartment of Chemistry, Jagannath University, Dhaka 1100, Bangladesh.ORCID 0000-0001-7568-5268
Youn Young ShimDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0002-5039-8219
Martin J T ReaneyDepartment of Plant Sciences, University of Saskatchewan, Saskatoon, SK S7N 5A8 Canada.
Jae Youl ChoDepartment of Integrative Biotechnology, Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-8141-9927

Funding

National Research Foundation of Korea 2017R1A6A1A03015642
6 · The paper itself

Abstract

Nanobiotechnology has grown rapidly and become an integral part of modern disease diagnosis and treatment. Biosynthesized silver nanoparticles (AgNPs) are a class of eco-friendly, cost-effective and biocompatible agents that have attracted attention for their possible biomedical and bioengineering applications. Like many other inorganic and organic nanoparticles, such as AuNPs, iron oxide and quantum dots, AgNPs have also been widely studied as components of advanced anticancer agents in order to better manage cancer in the clinic. AgNPs are typically produced by the action of reducing reagents on silver ions. In addition to numerous laboratory-based methods for reduction of silver ions, living organisms and natural products can be effective and superior source for synthesis of AgNPs precursors. Currently, plants, bacteria and fungi can afford biogenic AgNPs precursors with diverse geometries and surface properties. In this review, we summarized the recent progress and achievements in biogenic AgNPs synthesis and their potential uses as anticancer agents.

Indexed as

anti-cancer effectcancergreen chemistrysilver nanoparticles

Identifiers

PMID32244822
PMCPMC7226404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.